Bevacizumab in combination with cetuximab and irinotecan (BCI) after failure of cetuximab and irinotecan (CI) in patients with metastatic colorectal cancer (mCRC)

K Skougaard, Dorte Nielsen, Per Pfeiffer, Trine Lembrecht Jørgensen, Jon Kroll Bjerregaard, Benny Vittrup Jensen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Original languageEnglish
Publication date2009
Publication statusPublished - 2009
Event2009 ASCO Gastrointestinal Cancers Symposium - San Francisco, United States
Duration: 15. Jan 200917. Jan 2009

Conference

Conference2009 ASCO Gastrointestinal Cancers Symposium
Country/TerritoryUnited States
CitySan Francisco
Period15/01/200917/01/2009

Cite this